Nabulsi Azmi
SEC CIK 1791412 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | COO | 312.6K | $245.8K | $188.7K | 13 | 2022-01-19 | 2025-02-27 |
Most active insiders at PHAT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Breedlove Robert Charles | Principal Accounting Off | — | $7,079 |
| 2 | Narula Sanjeev | Chief Financial, Bus. Off | — | — |
| 3 | Parikh Asit | Dir | — | — |
| 4 | Stenhouse Mark | Dir | — | — |
| 5 | Basta Steven L | Pres, CEO, Dir | — | — |
| 6 | Schroeder Theodore R | Dir | — | — |
| 7 | Topper James N | Dir, 10% | — | — |
| 8 | Cook Anne Marie | Chief Legal Off, Corp. Sec | — | — |
| 9 | KARBE FRANK | Dir | — | — |
| 10 | COLA MICHAEL F | Dir | — | — |
Nabulsi Azmi made no open-market trades at PHAT in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-27 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +79.2K | 312.6K | +34% | $0 |
| 2025-01-23 | 2025-01-21 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | S - Sale | $6.59 | -7,886 | 233.4K | -3% | -$52.0K | |
| 2024-12-20 | 2024-12-19 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | S - Sale | $8.00 | -1,118 | 239.3K | -0.5% | -$8,944 | |
| 2024-07-17 | 2024-07-15 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | S - Sale | $11.72 | -10.9K | 240.4K | -4% | -$127.8K | |
| 2024-05-31 | 2024-05-31 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +7,500 | 249.6K | +3% | $0 | |
| 2023-11-03 | 2023-11-01 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +32.5K | 242.1K | +16% | $0 | |
| D | 2023-07-17 | 2023-07-14 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | — | +110.0K | 209.6K | +110% | — |
| 2023-04-11 | 2023-04-11 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | P - Purchase | $8.26 | +10.0K | 99.6K | +11% | +$82.6K | |
| D | 2023-01-20 | 2023-01-19 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +45.0K | 89.6K | +101% | $0 |
| 2022-09-02 | 2022-09-01 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +7,500 | 42.0K | +22% | $0 | |
| 2022-05-20 | 2022-05-19 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +12.0K | 33.4K | +56% | $0 | |
| I | 2022-05-16 | 2022-05-16 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | P - Purchase | $8.16 | +20.0K | 785.7K | +3% | +$163.2K |
| D | 2022-01-21 | 2022-01-19 | PHAT | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi | COO | A - Grant | $0.00 | +19.5K | 21.4K | +1,038% | $0 |
Purchase Sale Sale after option exercise All abbreviations